Assertion: severe aplastic anemia | /r/HasProperty | saa
Facets:
Source sentences:
text: Severe Aplastic Anemia (SAA)
text: Severe aplastic anemia (SAA)
text: Cyclosporine (Gengraf®, Neoral®) is an Immunotherapy Regimen for Severe Aplastic Anemia (SAA)
text: Severe Aplastic Anemia (SAA)
text: Severe Aplastic Anemia (SAA)
text: Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
text: When all 3 types of blood cells are very low in number, the person has severe aplastic anemia (SAA).
text: Hematologic disorders are very common in Systmic lupus erythematosus (SLE).First presentation of SLE with severe aplastic anemia (SAA) is extremely rare.
text: Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
text: Immunosuppressive therapy (IST) is the most used therapy, especially in patients older than 40 years suffering from severe aplastic anemia (SAA), very severe aplastic anemia (VSAA) and non-severe aplastic anemia who are transfusion dependent.
text: Hematopoietic cell transplantation (HCT) is indicated in patients with less than 40 years of age and suffering from severe aplastic anemia (SAA) or very severe aplastic anemia (VSAA).
text: What is severe aplastic anemia (SAA)?
text: Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
text: Severe aplastic anemia (SAA) is defined as marrow cellularity < 25% (or 25–50% with < 30% residual hematopoietic cells), plus at least two of the following peripheral blood findings: Neutrophils less than 0.5 × 10 9 /L
text: Severe Aplastic Anemia (SAA) is a disease in which the bone marrow production of all the normal components of blood - red cells, white cells and platelets - is reduced.
text: Our department treats many patients with severe aplastic anemia (SAA).
text: Severe aplastic anemia (SAA) has an aggressive clinical course and represents a "difficult-to-treat" situation with current medications
text: Survival in severe aplastic anemia (SAA) has markedly improved in the past 4 decades because of advances in hematopoietic stem cell transplantation, immunosuppressive biologics and drugs, and supportive care.
text: Until the 1970s, severe aplastic anemia (SAA) was almost uniformly fatal, but in the early 21st century most patients can be effectively treated and can expect long-term survival.